Fibrogenic cytokines in relation to inflammation and collagen deposition in inflammatory myopathies

Research output: Contribution to journalArticle

Abstract

The idiopathic inflammatory myopathies are diseases of unknown etiology characterized by T lymphocytemediated myocytotoxicity in polymyositis (PM) and complement-mediated angiopathy of muscle fibers in dermatomyositis (DM). Since a connective tissue proliferation has been described in PM and DM both perimysially and endomysially, we evaluated the expression of fibrogenic and immunomodulating cytokine TGF-βl by quantitative-polymerase chain reaction and immunocytochemistry in 11 DM and 8 PM muscle biopsies. We found significantly higher TGF-βl mRNA level in DM (0.46 ±0.45 fg/200 ng total RNA) than in controls (0.12 ±0.33) (P = 0.036), while in PM the cytokine level (0.33 ±0.19) did not differ significantly either from controls (P = 0.102) or DM (P = 0.487). By immunostaining TGF-βl was present in proliferated connective tissue but not in relation to mononuclear cell infiltrates. These findings suggest an active role of TGF-βl in fibrotic process in PM/DM muscles. Current studies on basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) may give new insights on the fibrogenic and immunomodulatory activity of these cytokines in inflammatory myopathies.

Original languageEnglish
Pages (from-to)106
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Myositis
Dermatomyositis
Collagen
Cytokines
Inflammation
Polymyositis
Muscles
Connective Tissue
Platelet-Derived Growth Factor
Fibroblast Growth Factor 2
Immunohistochemistry
RNA
Biopsy
Polymerase Chain Reaction
Messenger RNA

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

@article{f2e7fa112fc44d1aa988f14b0f1b225a,
title = "Fibrogenic cytokines in relation to inflammation and collagen deposition in inflammatory myopathies",
abstract = "The idiopathic inflammatory myopathies are diseases of unknown etiology characterized by T lymphocytemediated myocytotoxicity in polymyositis (PM) and complement-mediated angiopathy of muscle fibers in dermatomyositis (DM). Since a connective tissue proliferation has been described in PM and DM both perimysially and endomysially, we evaluated the expression of fibrogenic and immunomodulating cytokine TGF-βl by quantitative-polymerase chain reaction and immunocytochemistry in 11 DM and 8 PM muscle biopsies. We found significantly higher TGF-βl mRNA level in DM (0.46 ±0.45 fg/200 ng total RNA) than in controls (0.12 ±0.33) (P = 0.036), while in PM the cytokine level (0.33 ±0.19) did not differ significantly either from controls (P = 0.102) or DM (P = 0.487). By immunostaining TGF-βl was present in proliferated connective tissue but not in relation to mononuclear cell infiltrates. These findings suggest an active role of TGF-βl in fibrotic process in PM/DM muscles. Current studies on basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) may give new insights on the fibrogenic and immunomodulatory activity of these cytokines in inflammatory myopathies.",
author = "P. Confalonieri and P. Bernasconi and F. Cornelio and R. Mantegazza",
year = "1997",
language = "English",
volume = "18",
pages = "106",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Fibrogenic cytokines in relation to inflammation and collagen deposition in inflammatory myopathies

AU - Confalonieri, P.

AU - Bernasconi, P.

AU - Cornelio, F.

AU - Mantegazza, R.

PY - 1997

Y1 - 1997

N2 - The idiopathic inflammatory myopathies are diseases of unknown etiology characterized by T lymphocytemediated myocytotoxicity in polymyositis (PM) and complement-mediated angiopathy of muscle fibers in dermatomyositis (DM). Since a connective tissue proliferation has been described in PM and DM both perimysially and endomysially, we evaluated the expression of fibrogenic and immunomodulating cytokine TGF-βl by quantitative-polymerase chain reaction and immunocytochemistry in 11 DM and 8 PM muscle biopsies. We found significantly higher TGF-βl mRNA level in DM (0.46 ±0.45 fg/200 ng total RNA) than in controls (0.12 ±0.33) (P = 0.036), while in PM the cytokine level (0.33 ±0.19) did not differ significantly either from controls (P = 0.102) or DM (P = 0.487). By immunostaining TGF-βl was present in proliferated connective tissue but not in relation to mononuclear cell infiltrates. These findings suggest an active role of TGF-βl in fibrotic process in PM/DM muscles. Current studies on basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) may give new insights on the fibrogenic and immunomodulatory activity of these cytokines in inflammatory myopathies.

AB - The idiopathic inflammatory myopathies are diseases of unknown etiology characterized by T lymphocytemediated myocytotoxicity in polymyositis (PM) and complement-mediated angiopathy of muscle fibers in dermatomyositis (DM). Since a connective tissue proliferation has been described in PM and DM both perimysially and endomysially, we evaluated the expression of fibrogenic and immunomodulating cytokine TGF-βl by quantitative-polymerase chain reaction and immunocytochemistry in 11 DM and 8 PM muscle biopsies. We found significantly higher TGF-βl mRNA level in DM (0.46 ±0.45 fg/200 ng total RNA) than in controls (0.12 ±0.33) (P = 0.036), while in PM the cytokine level (0.33 ±0.19) did not differ significantly either from controls (P = 0.102) or DM (P = 0.487). By immunostaining TGF-βl was present in proliferated connective tissue but not in relation to mononuclear cell infiltrates. These findings suggest an active role of TGF-βl in fibrotic process in PM/DM muscles. Current studies on basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) may give new insights on the fibrogenic and immunomodulatory activity of these cytokines in inflammatory myopathies.

UR - http://www.scopus.com/inward/record.url?scp=33746334494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746334494&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746334494

VL - 18

SP - 106

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -